//
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Classification of Deaths in Cardiovascular Outcomes Trials Known Unknowns and Unknown Unknowns
Genotype-Guided Strategy for Oral P2Y12 Inhibitors
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents
Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations
Association Between Living in Food Deserts and Cardiovascular Risk
High-Risk Coronary Atherosclerosis Is It the Plaque Burden, the Calcium, the Lipid, or Something Else?
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial